SCM
Soleus Capital Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.8M | Sell |
2,243,935
-602,768
| -21% | -$21.7M | 5.35% | 3 |
|
|
2025
Q1 | $112M | Buy |
2,846,703
+165,461
| +6% | +$6.52M | 8.08% | 1 |
|
|
2024
Q4 | $80.7M | Buy |
2,681,242
+146,702
| +6% | +$4.42M | 5.07% | 2 |
|
|
2024
Q3 | $59.3M | Sell |
2,534,540
-1,111,022
| -30% | -$26M | 4.59% | 2 |
|
|
2024
Q2 | $64.9M | Buy |
3,645,562
+477,106
| +15% | +$8.49M | 5.72% | 1 |
|
|
2024
Q1 | $48.2M | Buy |
3,168,456
+2,518,456
| +387% | +$38.3M | 3.58% | 5 |
|
|
2023
Q4 | $11.1M | Sell |
650,000
-2,234,382
| -77% | -$38.2M | 1.23% | 27 |
|
|
2023
Q3 | $24.1M | Buy |
2,884,382
+2,448,882
| +562% | +$20.5M | 2.22% | 11 |
|
|
2023
Q2 | $10.8M | Sell |
435,500
-314,800
| -42% | -$7.82M | 1.2% | 24 |
|
|
2023
Q1 | $11.3M | Buy |
750,300
+512,300
| +215% | +$7.7M | 1.17% | 25 |
|
|
2022
Q4 | $2.82M | Buy |
+238,000
| New | +$2.82M | 0.4% | 49 |
|